A new product for management of dermatoses.
D000818:Animals; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D003881:Dermatomycoses / Q000188:drug therapy / Q000662:veterinary; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D009355:Neomycin / Q000009:adverse effects / Q000627:therapeutic use; D010032:Otitis Externa / Q000188:drug therapy / Q000662:veterinary; D012871:Skin Diseases / Q000188:drug therapy / Q000662:veterinary*; D013827:Thiabendazole / Q000009:adverse effects / Q000627:therapeutic use
D003907:Dexamethasone; D009355:Neomycin; D013827:Thiabendazole